Article
The efficacy and safety of pharmacotherapy for girls with central precocious puberty or early puberty: a retrospective cohort study
2024-06-12
Abstract excerpt
<title>Abstract</title> <p><bold>Purpose</bold>: The use of recombinant human growth hormone (rhGH) for central precocious puberty (CPP) and early puberty (EP) is off-label and lacks reliable evidence for clinical practice. This study aimed to compare the long-term efficacy and safety of gonadotrophin releasing hormone analogue (GnRHa) in combination with or without rhGH for the treatment of CPP and EP, and to ex...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- bdbca5cb-a5aa-5f5c-900d-4004101fe716
- DOI
- 10.21203/rs.3.rs-4474625/v1
